Commencez
BADQOMOCAWGOWLD

$OCGN Ocugen Inc Long term PTs 16 - 21 - 180 and higher

Long
Ocugen, Inc. (BATS:OCGN)  
BADQOMOCAWGOWLD  
BATS:OCGN   Ocugen, Inc.
Harmonic Patterns Chart Patterns Technical Indicators Contains IO script
2
2
harmonicpatterns chartpattern indicator containsioscript
OCGN Ocugen Inc
Long term PTs 16 - 21 - 180 and higher

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410 and OCU410ST for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. It has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.